Molecular Diagnostics
C-reactive Protein Level Can Replace Erythrocyte Sedimentation Rate for Defining the Severity of Ulcerative Colitis
A research team in Australia has determined that a blood level of C-reactive protein equal to or greater than 12 milligrams/liter is a practical alternative to measurement of ESR (Erythrocyte Sedimentation Rate) for defining the severity of ulcerative colitis. More...24 Feb 2022
LumiraDx C-Reactive Protein (CRP) Test Achieves CE Marking
LumiraDx (London, UK) has achieved CE Marking for its C-reactive protein (CRP) Test, a small, portable, fully automated, microfluidic immunoassay test used for the quantitative determination of C-reactive protein with results within four minutes. More...21 Feb 2022
Titin-Truncating Variant Associated With Late-Onset Dilated Cardiomyopathy
Late-onset dilated cardiomyopathy might represent a distinct disease subtype marked by an increased burden of genetic variants, a new study has found. The findings further suggested that genetic testing may be beneficial for older dilated cardiomyopathy patients. More...21 Feb 2022
New Pathogen Detection Assay Pairs Molecular Inversion Probes, Next-Generation Sequencing
Next-generation sequencing is rapidly finding footholds in numerous microbiological fields, including infectious disease diagnostics. Molecular inversion probe (MIP) technology can be coupled with next-generation sequencing (NGS) for targeted, multiplexed pathogen detection. More...21 Feb 2022
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Human Estradiol Assay
Human Estradiol CLIA Kit
Laboratory Software
ArtelWare
In Other News
Metabolomics-Based Test Detects Early-Stage Lung Cancer and Predicts Patient Survival Time
Sensitive Protein Assay Differentiates Parkinson’s Disease from Other Synucleinopathies
World's First Genomic Test for Personalized HER2+ Breast Cancer Treatment Could Revolutionize Precision Oncology
dd-cfDNA Test for Assessing Kidney Transplant Rejection Performs Strongly in Real-World Study
CRISPR-based Assay Platform Detects Multiple Viruses and COVID-19 Variants
New In-Vitro Diagnostic Kits Help Patients Fight Cancer in Europe
Personalized Molecular Monitoring Assay Uses Algorithms for Early Detection of ctDNA
Molecular Profiling of Meningioma Leads to Improved Prognosis and Therapy
Aptamer-Based Test Identifies Biomarkers Linked to Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
Rapid, Cheaper Test Identifies Specific Genetic Mutations in Patient’s Cancer Cells for Personalized Therapy
Certain Childhood ALL Subtypes Linked to Genetic Ancestry
Intestinal Microbiota Determines the Risk of MDRO Acquisition
Blood Biomarkers May Distinguish Dementia Disorders
Biomarker Panel Predicts Depressive Symptoms in Pregnant and Postprartum Women
Novel Urinary miRNA Biomarker for Early Detection of Colorectal Cancer
Genetic Clues Link Lipoprotein A to Prostate Cancer Risk
RNA Sequencing Improves Gene Fusion Detection for Childhood Cancer Diagnostics
Microfluidic Gated Device for Extraction of Cell-Free DNA Could Help Accurately Diagnose Infections from Small Blood Sample
New High-Throughput Microscopy and Machine Learning Systems Identify and Classify DNA Repair Factors
High-Speed Fluorescence Image-Enabled Cell Sorting Tested
Novel Blood Test Diagnoses Newborns with Rare Genetic Disorders
Transcriptomic Analysis Reveals Proinflammatory Signatures Associated with AML Progression
Meridian Bioscience Launches Two New Master Mixes That Detect DNA and RNA in Crude Saliva Samples
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.